Ipamorelin is a synthetic pentapeptide that mimics the action of endogenous ghrelin. As a specialized agonist of the Growth Hormone Secretagogue Receptor (GHS-R1a), it targets the somatotroph cells in the anterior pituitary. Ipamorelin is unique among GHRPs for its extreme selectivity, offering researchers a model to study growth hormone axes without the interference of secondary hormonal surges.
Key Research Areas:
- Exceptional Receptor Selectivity: Ipamorelin is distinguished by its “clean” profile. Unlike GHRP-2 or Hexarelin, research indicates that Ipamorelin does not induce the release of ACTH, cortisol, prolactin, or TSH, making it an ideal candidate for studies focused purely on the somatotropic axis.
- Amplified GH Secretion: In clinical research models, Ipamorelin has been observed to elevate GH concentrations to approximately 80 mIU/l—a staggering 60-fold increase over placebo baseline levels. This is achieved via the PLC/IP3 signaling pathway, which triggers calcium ion release and vesicle exocytosis.
- IGF-1 & Anabolic Signaling: Studies suggest Ipamorelin not only triggers GH release but also stimulates the expression of Insulin-like Growth Factor-1 (IGF-1). Additionally, it may inhibit somatostatin, the hormone responsible for blunting growth hormone production.
- Metabolic & Structural Growth: Ipamorelin is frequently utilized in animal models to study muscle development, bone mineralization, and cellular repair, leveraging the main anabolic mediators of the GH pathway.
- Gastric & Cognitive Function: As a ghrelin receptor agonist, research explores its potential impact on gastric emptying and gut motility, as well as its hypothesized role in sleep cycle regulation.
Elite Peptide Supply provides ultra-pure Ipamorelin for precision laboratory experimentation. Our pentapeptide is verified for sequence integrity to ensure the high-affinity binding required for elite-level endocrine research.
Reviews
There are no reviews yet.